We serve Chemical Name:5-hydroxy-7-methylnaphthalene-1,4-dione CAS:14787-38-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-hydroxy-7-methylnaphthalene-1,4-dione
CAS.NO:14787-38-3
Synonyms:7-Methyljuglon;JUGLONE,7-METHYL;7-Methyljuglone;7-methyl-5-hydroxy-1,4-naphthoquinone;Ramentaceone
Molecular Formula:C11H8O3
Molecular Weight:188.17900
HS Code:2914690090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:427.2ºC at 760mmHg
Density:1.371g/cm3
Index of Refraction:1.642
PSA:54.37000
Exact Mass:188.04700
LogP:1.63580
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 7-Methyljuglon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ramentaceone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-methyl-5-hydroxy-1,4-naphthoquinone Use and application,Ramentaceone technical grade,usp/ep/jp grade.
Related News: The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. 5-hydroxy-7-methylnaphthalene-1,4-dione manufacturer However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 5-hydroxy-7-methylnaphthalene-1,4-dione supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-hydroxy-7-methylnaphthalene-1,4-dione vendor The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. 5-hydroxy-7-methylnaphthalene-1,4-dione factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.
